DK0801559T3 - Fremgangsmåde til fremstilling af orale doseringsformer indeholdende et beta-lactam antibiotikum - Google Patents
Fremgangsmåde til fremstilling af orale doseringsformer indeholdende et beta-lactam antibiotikumInfo
- Publication number
- DK0801559T3 DK0801559T3 DK96904039T DK96904039T DK0801559T3 DK 0801559 T3 DK0801559 T3 DK 0801559T3 DK 96904039 T DK96904039 T DK 96904039T DK 96904039 T DK96904039 T DK 96904039T DK 0801559 T3 DK0801559 T3 DK 0801559T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- beta
- lactam antibiotic
- preparation
- granulate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP95200313 | 1995-02-08 | ||
PCT/EP1996/000547 WO1996024337A1 (en) | 1995-02-08 | 1996-02-08 | ORAL DOSAGE-FORMS CONTAINING A β-LACTAM ANTIBIOTIC |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0801559T3 true DK0801559T3 (da) | 2002-06-17 |
Family
ID=8220003
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96904039T DK0801559T3 (da) | 1995-02-08 | 1996-02-08 | Fremgangsmåde til fremstilling af orale doseringsformer indeholdende et beta-lactam antibiotikum |
Country Status (19)
Country | Link |
---|---|
US (1) | US5948422A (da) |
EP (1) | EP0801559B1 (da) |
CN (1) | CN1125636C (da) |
AT (1) | ATE216576T1 (da) |
AU (1) | AU4789696A (da) |
BG (1) | BG63528B1 (da) |
BR (1) | BR9607189A (da) |
CZ (1) | CZ293718B6 (da) |
DE (1) | DE69620866T2 (da) |
DK (1) | DK0801559T3 (da) |
EA (2) | EA000361B1 (da) |
ES (1) | ES2175073T3 (da) |
HU (1) | HU227938B1 (da) |
MX (1) | MX9706062A (da) |
NO (1) | NO319993B1 (da) |
PL (1) | PL186386B1 (da) |
PT (1) | PT801559E (da) |
WO (1) | WO1996024337A1 (da) |
ZA (1) | ZA961018B (da) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI225402B (en) * | 1996-03-13 | 2004-12-21 | Biochemie Gmbh | Auxiliary-free agglomerates |
CN1225583A (zh) * | 1996-07-16 | 1999-08-11 | 吉斯特-布罗卡迪斯有限公司 | 无有机溶剂的β-内酰胺颗粒 |
US6080427A (en) * | 1997-04-17 | 2000-06-27 | Bristol-Myers Squibb Company | Cefadroxil monohydrate tablet formulation |
EP1058538B9 (en) * | 1998-03-06 | 2013-01-02 | Aptalis Pharma S.r.l. | Fast disintegrating tablets |
US7399751B2 (en) * | 1999-11-04 | 2008-07-15 | Sertoli Technologies, Inc. | Production of a biological factor and creation of an immunologically privileged environment using genetically altered Sertoli cells |
DE19922537A1 (de) * | 1999-05-10 | 2000-11-16 | Roland Bodmeier | Darreichungsform zur Applikation in Körperöffnungen |
WO2002024230A1 (fr) * | 2000-09-22 | 2002-03-28 | Takeda Chemical Industries, Ltd. | Preparations solides |
GB0102342D0 (en) * | 2001-01-30 | 2001-03-14 | Smithkline Beecham Plc | Pharmaceutical formulation |
CZ20032138A3 (cs) * | 2001-02-05 | 2005-03-16 | R. P. Scherer Technologies, Inc. | Způsoby a prostředky pro zeslabení chuti farmaceuticky aktivních činidel |
CA2478411C (en) * | 2002-03-12 | 2010-09-28 | Bristol-Myers Squibb Company | Palatable oral suspension and method |
WO2004030673A1 (ja) * | 2002-10-02 | 2004-04-15 | Meiji Seika Kaisha, Ltd. | 経口吸収性が改善された抗菌性医薬組成物 |
DK1803444T3 (da) * | 2002-12-20 | 2019-02-25 | Niconovum Ab | Fremgangsmåde til fremstilling af et nikotinholdigt partikelformigt materiale med en krystallinsk cellulose (især mcc) |
JP4926703B2 (ja) * | 2003-07-03 | 2012-05-09 | セルトリ・テクノロジーズ・エルエルシー | セルトリ細胞および筋様細胞を含有する組成物、並びに細胞性移植における該組成物の使用 |
US20050089502A1 (en) * | 2003-08-21 | 2005-04-28 | Todd Schansberg | Effervescent delivery system |
CA2626933C (en) | 2005-11-17 | 2015-12-29 | Novartis Ag | Pharmaceutical composition |
WO2007104573A2 (en) | 2006-03-16 | 2007-09-20 | Niconovum Ab | Improved snuff composition |
US8617597B2 (en) | 2006-07-06 | 2013-12-31 | Bayer Intellectual Property Gmbh | Pharmaceutical composition containing a tetrahydrofolic acid |
JP2010500871A (ja) * | 2006-07-28 | 2010-01-14 | セルトセル・バイオテクノロジー・(ユーエス)・コーポレイション | 成熟セルトリ細胞およびその使用 |
CA2736531C (en) * | 2008-09-17 | 2016-10-25 | Niconovum Ab | Process for preparing snuff composition |
EP2367422A4 (en) * | 2008-12-17 | 2013-01-09 | Altheus Therapeutics Inc | FORMULAS FOR LAVATION |
WO2023204773A1 (en) * | 2022-04-20 | 2023-10-26 | Bilim Ilac Sanayii Ve Ticaret A.S. | Tablet formulations for the treatment of urinary system infections and method for the preparation of such formulations |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3344030A (en) * | 1964-06-15 | 1967-09-26 | American Home Prod | Reinforced directly compressed nongranulated pharmaceutical crystalline lactose tables |
DE2251250C3 (de) * | 1972-10-19 | 1981-06-25 | Hoechst Ag, 6230 Frankfurt | Verfahren zur Herstellung hochdosierter Antibiotica-Tabletten |
DE2251249A1 (de) * | 1972-10-19 | 1974-05-02 | Hoechst Ag | Verfahren zur herstellung von penicillin-verbindungen enthaltenden tabletten |
DE3887179T2 (de) * | 1987-03-02 | 1994-06-16 | Brocades Pharma Bv | Pharmazeutische Zusammensetzung, pharmazeutisches Granulat und Verfahren zu ihrer Herstellung. |
US5049394A (en) * | 1987-09-11 | 1991-09-17 | E. R. Squibb & Sons, Inc. | Pharmaceutical composition containing high drug load and method for preparing same |
ES2060737T3 (es) * | 1988-02-25 | 1994-12-01 | Yamanouchi Europ Bv | Procedimiento de preparacion de un granulado farmaceutico. |
US5643591A (en) * | 1991-01-16 | 1997-07-01 | Fmc Corporation | Solid dosage forms |
EP0755258B1 (en) * | 1994-04-13 | 2002-01-23 | Research Corporation Technologies, Inc | Methods of treating disease using sertoli cells and allografts or xenografts |
US5605889A (en) * | 1994-04-29 | 1997-02-25 | Pfizer Inc. | Method of administering azithromycin |
-
1996
- 1996-02-08 ES ES96904039T patent/ES2175073T3/es not_active Expired - Lifetime
- 1996-02-08 BR BR9607189A patent/BR9607189A/pt active Search and Examination
- 1996-02-08 EA EA199700093A patent/EA000361B1/ru not_active IP Right Cessation
- 1996-02-08 MX MX9706062A patent/MX9706062A/es unknown
- 1996-02-08 EA EA199900205A patent/EA003736B1/ru not_active IP Right Cessation
- 1996-02-08 PL PL96321567A patent/PL186386B1/pl unknown
- 1996-02-08 WO PCT/EP1996/000547 patent/WO1996024337A1/en active IP Right Grant
- 1996-02-08 DK DK96904039T patent/DK0801559T3/da active
- 1996-02-08 HU HU9801677A patent/HU227938B1/hu not_active IP Right Cessation
- 1996-02-08 AT AT96904039T patent/ATE216576T1/de active
- 1996-02-08 PT PT96904039T patent/PT801559E/pt unknown
- 1996-02-08 CZ CZ19972302A patent/CZ293718B6/cs not_active IP Right Cessation
- 1996-02-08 EP EP96904039A patent/EP0801559B1/en not_active Expired - Lifetime
- 1996-02-08 ZA ZA9601018A patent/ZA961018B/xx unknown
- 1996-02-08 CN CN96191852A patent/CN1125636C/zh not_active Expired - Fee Related
- 1996-02-08 US US08/894,602 patent/US5948422A/en not_active Expired - Lifetime
- 1996-02-08 AU AU47896/96A patent/AU4789696A/en not_active Abandoned
- 1996-02-08 DE DE69620866T patent/DE69620866T2/de not_active Expired - Lifetime
-
1997
- 1997-08-07 NO NO19973646A patent/NO319993B1/no not_active IP Right Cessation
- 1997-08-08 BG BG101822A patent/BG63528B1/bg unknown
Also Published As
Publication number | Publication date |
---|---|
BG101822A (en) | 1998-04-30 |
CZ293718B6 (cs) | 2004-07-14 |
ATE216576T1 (de) | 2002-05-15 |
ES2175073T3 (es) | 2002-11-16 |
US5948422A (en) | 1999-09-07 |
EA003736B1 (ru) | 2003-08-28 |
HUP9801677A3 (en) | 1999-05-28 |
WO1996024337A1 (en) | 1996-08-15 |
CN1125636C (zh) | 2003-10-29 |
NO973646D0 (no) | 1997-08-07 |
HU227938B1 (en) | 2012-06-28 |
EA199900205A1 (ru) | 2000-06-26 |
CN1173816A (zh) | 1998-02-18 |
NO319993B1 (no) | 2005-10-10 |
ZA961018B (en) | 1997-08-08 |
NO973646L (no) | 1997-09-11 |
AU4789696A (en) | 1996-08-27 |
BR9607189A (pt) | 1997-11-11 |
PT801559E (pt) | 2002-09-30 |
CZ230297A3 (en) | 1997-11-12 |
EA199700093A1 (ru) | 1998-02-26 |
HUP9801677A2 (hu) | 1998-11-30 |
MX9706062A (es) | 1997-10-31 |
EP0801559A1 (en) | 1997-10-22 |
DE69620866T2 (de) | 2003-02-27 |
PL186386B1 (pl) | 2004-01-30 |
DE69620866D1 (de) | 2002-05-29 |
EA000361B1 (ru) | 1999-06-24 |
EP0801559B1 (en) | 2002-04-24 |
BG63528B1 (bg) | 2002-04-30 |
PL321567A1 (en) | 1997-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0801559T3 (da) | Fremgangsmåde til fremstilling af orale doseringsformer indeholdende et beta-lactam antibiotikum | |
DE59510740D1 (de) | Pharmazeutische zubereitung enthaltend metformin und verfahren zu deren herstellung | |
SE9502244D0 (sv) | A composition and a process for the preparation thereof | |
MY116124A (en) | Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug | |
NO971986L (no) | Fremgangsmåte for fremstilling av små partikler | |
ES2132415T3 (es) | Nuevos derivados de 5-pirrolil-2-piridilmetilsulfinilbencimidazol. | |
PT847273E (pt) | Composicao farmaceutica melhorada de resina de permuta ionica | |
FI971172A (fi) | Menetelmä annosyksikköjen valmistamiseksi märkärakeistamalla | |
ZA959451B (en) | 2,2-Dichloroalkanecarboxylic acids process of their production and pharmaceutical agents containing these | |
BR9609964A (pt) | Formulação sólida estável de sal de enalaprila e processo para preparação da mesma | |
HU9601321D0 (en) | Substituted (benzyloxy)-carbonyl-guanidine derivatives, process for producing them, their use as pharmaceutical compositions or diagnostica, and pharmaceutical compositions containing them | |
WO1997010810A3 (en) | Pharmaceutical granules | |
BR9610175A (pt) | Composto processo de preparação do composto composição farmacêutica e utilização do composto | |
DE69102143T2 (de) | Spiramycin enthaltende arzneimittel und verfahren zu deren herstellung. | |
HUT71491A (en) | Tablet, capsule, or granule comprising desogestrel and process for preparation thereof | |
ES2137665T3 (es) | Nuevos derivados de piridina o piridazina, procedimientos para su preparacion, y medicamentos que contienen estos compuestos. | |
TW334424B (en) | L-arginine aldehyde derivatives process for preparing them and pharmaceutical composition | |
IL117734A0 (en) | Beta-carbolines and pharmaceutical compositions containing them | |
YU46792B (sh) | Kipuća tableta za dezinfekciju vode na bazi hloramina i postupak za njihovu proizvodnju |